Compare
Jushi Holdings Inc. vs biote Corp. vs Marimed Inc. vs Cronos Group Inc.
| Latest fiscal year | Jushi Holdings Inc. JUSH | biote Corp. BTMD | Marimed Inc. MRMD | Cronos Group Inc. CRON |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $262.91M | $192.22M | $159.83M | $146.59M |
| Revenue growth (YoY) | +2.1% | -2.5% | +1.3% | +24.6% |
| Gross margin | 43.4% | n/a | 36.2% | 42.8% |
| Operating margin | 1.8% | 18.5% | -1.8% | -11.9% |
| Net margin | -26.1% | 14.1% | -9.1% | -6.4% |
| Net income | -$68.59M | $27.05M | -$14.48M | -$9.45M |
| EPS (Diluted) | -$0.35 | $0.74 | -$0.04 | -$0.02 |
| Operating cash flow | $17.73M | $35.19M | $7.70M | $25.87M |
| Free cash flow | $1.64M | $30.18M | $6.53M | $149.0K |
| Cash & equivalents | $24.05M | $24.12M | n/a | $791.79M |
| Total assets | $422.34M | $107.61M | $202.56M | $1.20B |
| Total liabilities | $537.69M | $158.01M | $137.83M | $54.18M |
| Shareholders' equity | -$115.34M | -$58.54M | $50.01M | $1.14B |
| Return on year-end equity | n/a | n/a | -29.0% | -0.8% |
| Shares outstanding | n/a | n/a | 396.91M | 381.59M |
Revenue, most recent five fiscal years
| Fiscal year | Jushi Holdings Inc. | biote Corp. | Marimed Inc. | Cronos Group Inc. |
|---|---|---|---|---|
| Latest | $262.91M Ended 2025-12-31 | $192.22M Ended 2025-12-31 | $159.83M Ended 2025-12-31 | $146.59M Ended 2025-12-31 |
| 1 year earlier | $257.52M Ended 2024-12-31 | $197.19M Ended 2024-12-31 | $157.71M Ended 2024-12-31 | $117.61M Ended 2024-12-31 |
| 2 years earlier | $269.44M Ended 2023-12-31 | $185.36M Ended 2023-12-31 | $148.60M Ended 2023-12-31 | $87.24M Ended 2023-12-31 |
| 3 years earlier | $284.28M Ended 2022-12-31 | $164.96M Ended 2022-12-31 | $134.01M Ended 2022-12-31 | $86.75M Ended 2022-12-31 |
| 4 years earlier | $209.29M Ended 2021-12-31 | $139.40M Ended 2021-12-31 | $121.46M Ended 2021-12-31 | $64.56M Ended 2021-12-31 |